What development phase is Scarlet Ointment in?

Scarlet Ointment is FDA-approved (marketed).

What is the generic name of Scarlet Ointment?

SCARLET RED is the generic (nonproprietary) name of Scarlet Ointment.

Last reviewed 2026-04-20 · How we verify

Scarlet Ointment (SCARLET RED)

FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	SCARLET RED
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Combination Study of Antibiotics With Enzalutamide (PROMIZE) (PHASE1,PHASE2)
New Treatment for Donor Sites (PHASE2,PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Scarlet Ointment CI brief — competitive landscape report
Scarlet Ointment updates RSS · CI watch RSS